| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a4a1e9593b4743b897481773bc06c91 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate |
2007-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7350dcf50097bf9a0246c72a37cc4852
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_015b9f9362cb9fa5d7e96bc1e9250f63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa995fe055a9113dedd90f9dc9e4ae63 |
| publicationDate |
2013-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-101516353-B |
| titleOfInvention |
Controlled release oral dosage formulations comprising a core and one or more barrier layers |
| abstract |
Controlled release oral dosage formulations containing one or more active agent, and methods of use thereof, are provided for the once-a-day treatment. The formulation can be in the form of a trilayer tablet containing a core or central layer and one or more barrier layers. The core may contain one or more enteric materials or polymeric materials which modulates the release of the active agent. |
| priorityDate |
2006-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |